Genentech Age-related Macular Degeneration Research Fellowships
As many as 11 million people in the United States have some form of age-related macular degeneration. This number is expected to double to nearly 22 million by 2050. The impact of age-related macular degeneration on the global aging population is enormous as people are deprived of their economic livelihoods and independence. Eye and vision researchers have already discovered several genes at work in AMD, the distinctions between types of AMD and the development of therapeutic remedies. The ARVO Foundation for Eye Research believes the work must continue so that there can be earlier identification of those likely to develop AMD, discovery of ways to slow the progression of the disease and novel ways to treat AMD to limit sight loss. Thanks to Genentech's support, the ARVO Foundation will offer one grant to a researcher working in basic research in the understanding of AMD and another grant to a researcher working in translational AMD research focusing on therapeutics.
View the 2016 Genentech Age-related Macular Degeneration Research Fellowships recipients.
The Genentech Age-related Macular Degeneration (AMD) Research Fellowships were created in 2011. They are made available through the support of Genentech. View previous recipients.
2016 Genentech AMD Fellowships timeline
||October 31, 2016